Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes

• Hideki Nakasone,
• Bita Sahaf,
• Lu Tian,
• Tao Wang,
• Michael D. Haagenson,
• Kelsi Schoenrock,
• Spenser Perloff,
• Christine E. Ryan,
• Fang Wu,
• Stephen R. Spellman,
• Stephanie J. Lee,
• Jerome Ritz,
• David B. Miklos

Affiliations

Hideki Nakasone

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA;Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan

Bita Sahaf

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA

Lu Tian

Health Research and Policy, Stanford University School of Medicine, CA, USA

Tao Wang

Center for International Blood and Marrow Transplant Research and Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA

Michael D. Haagenson

Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA

Kelsi Schoenrock

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA

Spenser Perloff

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA

Christine E. Ryan

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA

Fang Wu

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA

Stephen R. Spellman

Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA

Stephanie J. Lee

Center for International Blood and Marrow Transplant Research and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Jerome Ritz

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

David B. Miklos

Division of Blood and Marrow Transplantation, Stanford University School of Medicine, CA, USA